title: Consideration of use of neuraminidase inhibitors such as oseltamivir and zanamivir in IgA nephropathy.
authors.forename: Eric Lewin
authors.initials: EL
authors.lastname: Altschuler
authors.forename: Ajay
authors.initials: A
authors.lastname: Bhatia
authors.forename: Richard E
authors.initials: RE
authors.lastname: Kast
mesh_terms: D000081:Acetamides / Q000627:therapeutic use*; D000818:Animals; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005922:Glomerulonephritis, IGA / Q000188:drug therapy*; D006146:Guanidines / Q000627:therapeutic use*; D006801:Humans; D009439:Neuraminidase / Q000037:antagonists & inhibitors*; D053139:Oseltamivir; D011714:Pyrans / Q000627:therapeutic use*; D012794:Sialic Acids / Q000627:therapeutic use*; D053243:Zanamivir
chemical_list: D000081:Acetamides; D004791:Enzyme Inhibitors; D006146:Guanidines; D011714:Pyrans; D012794:Sialic Acids; D053139:Oseltamivir; D009439:Neuraminidase; D053243:Zanamivir